Therefore, concurrently inhibiting both IDO1 expression and activity may yield a more effective anti‐tumor response than using IDO enzyme activity inhibitors alone, supported by our findings that lacidipine significantly enhanced T cell proliferation. Here, IDO1 is linked to neoplasm.